Angina Pectoris Linked to Worse HRQoL in Heart Failure

Share this content:
Angina Pectoris Linked to Worse HRQoL in Heart Failure
Angina Pectoris Linked to Worse HRQoL in Heart Failure

THURSDAY, Oct. 20, 2016 (HealthDay News) -- For patients with heart failure with reduced ejection fraction, angina pectoris (AP) is associated with worse health-related quality of life (HRQoL) and depressive symptoms, according to a study published in the Oct. 15 issue of The American Journal of Cardiology.

Kishan S. Parikh, M.D., from the Duke Clinical Research Institute in Durham, N.C., and colleagues grouped 2,331 patients with heart failure with reduced ejection fraction from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training trial according to whether they had self-reported AP by Canadian classification score. HRQoL and clinical outcomes by AP status were examined.

The researchers found that 406 patients (17 percent) had AP at baseline; the severity of heart failure was similar to those without AP. Baseline exercise capacity was similar for patients with AP, but depressive symptoms and HRQoL were worse. AP correlated with a 22 percent increased adjusted risk for all-cause mortality/hospitalizations, which was driven by hospitalizations. Baseline AP was significantly associated with exercise training peak maximum volume of oxygen (VO2) change (P = 0.019); there were no correlations for other end points. In patients with AP, exercise training correlated with greater peak VO2 improvements after three months (treatment effect = 1.25 ml/kg/min).

"AP was associated with worse HRQoL and depressive symptoms," the authors write. "Despite greater peak VO2 improvement with exercise training, patients with AP experienced more adverse outcomes."

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »